These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18759509)

  • 1. Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.
    Gartlehner G; Thieda P; Hansen RA; Gaynes BN; Deveaugh-Geiss A; Krebs EE; Lohr KN
    Drug Saf; 2008; 31(10):851-65. PubMed ID: 18759509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis.
    Gartlehner G; Thaler K; Hansen RA; Gaynes BN
    Drug Saf; 2009; 32(12):1159-73. PubMed ID: 19916583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.
    Gartlehner G; Gaynes BN; Hansen RA; Thieda P; DeVeaugh-Geiss A; Krebs EE; Moore CG; Morgan L; Lohr KN
    Ann Intern Med; 2008 Nov; 149(10):734-50. PubMed ID: 19017592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.
    Hansen RA; Gartlehner G; Lohr KN; Gaynes BN; Carey TS
    Ann Intern Med; 2005 Sep; 143(6):415-26. PubMed ID: 16172440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.
    Reichenpfader U; Gartlehner G; Morgan LC; Greenblatt A; Nussbaumer B; Hansen RA; Van Noord M; Lux L; Gaynes BN
    Drug Saf; 2014 Jan; 37(1):19-31. PubMed ID: 24338044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis.
    Gartlehner G; Hansen RA; Morgan LC; Thaler K; Lux L; Van Noord M; Mager U; Thieda P; Gaynes BN; Wilkins T; Strobelberger M; Lloyd S; Reichenpfader U; Lohr KN
    Ann Intern Med; 2011 Dec; 155(11):772-85. PubMed ID: 22147715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis.
    Wagner G; Schultes MT; Titscher V; Teufer B; Klerings I; Gartlehner G
    J Affect Disord; 2018 Mar; 228():1-12. PubMed ID: 29197738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.
    Gartlehner G; Hansen RA; Carey TS; Lohr KN; Gaynes BN; Randolph LC
    Int Clin Psychopharmacol; 2005 Mar; 20(2):59-69. PubMed ID: 15729080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-generation antidepressants for preventing seasonal affective disorder in adults.
    Gartlehner G; Nussbaumer B; Gaynes BN; Forneris CA; Morgan LC; Kaminski-Hartenthaler A; Greenblatt A; Wipplinger J; Lux LJ; Sonis JH; Hofmann J; Van Noord MG; Winkler D
    Cochrane Database Syst Rev; 2015 Nov; (11):CD011268. PubMed ID: 26558418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis.
    Nussbaumer B; Morgan LC; Reichenpfader U; Greenblatt A; Hansen RA; Van Noord M; Lux L; Gaynes BN; Gartlehner G
    CNS Drugs; 2014 Aug; 28(8):699-712. PubMed ID: 24794101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.
    Thaler KJ; Morgan LC; Van Noord M; Gaynes BN; Hansen RA; Lux LJ; Krebs EE; Lohr KN; Gartlehner G
    Depress Anxiety; 2012 Jun; 29(6):495-505. PubMed ID: 22553134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians.
    Gartlehner G; Gaynes BN; Amick HR; Asher GN; Morgan LC; Coker-Schwimmer E; Forneris C; Boland E; Lux LJ; Gaylord S; Bann C; Pierl CB; Lohr KN
    Ann Intern Med; 2016 Mar; 164(5):331-41. PubMed ID: 26857743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani].
    Gaillard R
    Encephale; 2009 Oct; 35(5):499-504. PubMed ID: 19853726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis.
    Oliva V; Lippi M; Paci R; Del Fabro L; Delvecchio G; Brambilla P; De Ronchi D; Fanelli G; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110266. PubMed ID: 33549697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants.
    Hansen R; Gaynes B; Thieda P; Gartlehner G; Deveaugh-Geiss A; Krebs E; Lohr K
    Psychiatr Serv; 2008 Oct; 59(10):1121-30. PubMed ID: 18832497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-generation antidepressants for seasonal affective disorder.
    Thaler K; Delivuk M; Chapman A; Gaynes BN; Kaminski A; Gartlehner G
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008591. PubMed ID: 22161433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.